Peter A Holmans Selected Research

Peter A Holmans Research Topics

12	Schizophrenia (Dementia Praecox) 01/2023 - 04/2002
7	Bipolar Disorder (Manic Depressive Psychosis) 01/2023 - 05/2006
6	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 05/2006
2	Genetic Risk Score 01/2023 - 01/2021
2	Mental Disorders (Mental Disorder) 01/2021 - 01/2021
2	Psychotic Disorders (Schizoaffective Disorder) 10/2010 - 05/2006
1	Neurodevelopmental Disorders 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Hypoxia (Hypoxemia) 01/2017
1	Intellectual Disability (Idiocy) 03/2011
1	Infections 08/2009

3	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2017
2	Histones (Histone)IBA 10/2022 - 08/2009
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2019
2	Apolipoproteins E (ApoE)IBA 01/2021 - 05/2006
2	LipidsIBA 09/2019 - 01/2019
2	DysbindinIBA 04/2008 - 05/2006
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Histone MethyltransferasesIBA 10/2022
1	Antipsychotic Agents (Antipsychotics)IBA 03/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	Potassium Channels (Potassium Channel)IBA 01/2021
1	CalciumIBA 01/2021
1	CationsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Calcium Channels (Calcium Channel)IBA 01/2021
1	sharpinIBA 01/2021
1	FurinIBA 01/2021
1	Fragile X Mental Retardation ProteinIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	AntigensIBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	mitoquinoneIBA 01/2017
1	AntioxidantsIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2014
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 03/2011
1	CholesterolIBA 11/2010
1	GABA-A Receptors (GABA(A) Receptor)IBA 10/2010
1	ChromatinIBA 08/2009
1	AnkyrinsIBA 09/2008
1	Neuregulin-1 (Neuregulin 1)IBA 04/2008
1	Genetic Markers (Genetic Marker)IBA 04/2002